Loading...
TRIM32 promotes proliferation and confers chemoresistance to breast cancer cells through activation of the NF-κB pathway
Dysregulation of TRIM32 has been implicated in several human cancers, however, its clinical significance and biological function in breast cancer have not been investigated. Using immunohistochemistry, we found that TRIM32 expression is upregulated in breast cancer tissues and that it correlates wit...
Na minha lista:
| Udgivet i: | J Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Ivyspring International Publisher
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5929078/ https://ncbi.nlm.nih.gov/pubmed/29721043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.22390 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|